Both in Pharmaceuticals
Zevra Therapeutics vs Apnimed
Over the past year ZVRA returned −14.6% and APMD returned −42.6%; their daily moves had a correlation of 0.17.
ZVRA −14.6% APMD −42.6%Growth of $1, one year, split-adjusted
| Metric | ZVRA | APMD |
|---|---|---|
| Price | $10.26 | $15.06 |
| Market cap | $609.3M | $627.0M |
| Today | +1.58% | −2.21% |
| 1 month | −4.1% | −30.8% |
| 6 months | −3.3% | — |
| Year to date | +14.5% | — |
| 1 year | +0.8% | — |
| Revenue growth (YoY) | +53.3% | — |
| Gross margin | 96.2% | — |
| Net margin | 21.2% | — |
| P/E (TTM) | 10.5× | — |
| Price / sales | 4.5× | — |
| Net cash | $221.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | 44.3% | — |
| Short % of float | 10.8% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).